Literature DB >> 3623350

Studies on the metabolism of deoxynivalenol in the rat.

B G Lake, J C Phillips, D G Walters, D L Bayley, M W Cook, L V Thomas, J Gilbert, J R Startin, N C Baldwin, B W Bycroft.   

Abstract

The metabolism and tissue distribution of [14C]deoxynivalenol have been studied in male PVG rats. Following administration of a single oral 10-mg/kg dose, radioactivity excreted in the urine and faeces accounted, respectively, for 25 and 64% of the administered dose within 96 hr. Less than 0.15% of the dose was detected in the respired air. Very little radioactivity appeared to be retained in any of the tissues examined after 96 hr. HPLC separation of several urinary and faecal metabolites was achieved on a reversed-phase column, using two different elution systems, one at neutral pH and one acidified. Two of the major non-polar HPLC peaks were identified by gas chromatography-mass spectrometry as unchanged deoxynivalenol and 3 alpha,7 alpha,15-trihydroxytrichothec-9,12-dien-8-one.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3623350     DOI: 10.1016/0278-6915(87)90019-6

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  8 in total

1.  Kinetics of satratoxin g tissue distribution and excretion following intranasal exposure in the mouse.

Authors:  Chidozie J Amuzie; Zahidul Islam; Jae Kyung Kim; Ji-Hyun Seo; James J Pestka
Journal:  Toxicol Sci       Date:  2010-05-13       Impact factor: 4.849

Review 2.  Toxicokinetics and metabolism of deoxynivalenol in animals and humans.

Authors:  Yu Sun; Jun Jiang; Peiqiang Mu; Ruqin Lin; Jikai Wen; Yiqun Deng
Journal:  Arch Toxicol       Date:  2022-07-28       Impact factor: 6.168

3.  Immunochemical assessment of deoxynivalenol tissue distribution following oral exposure in the mouse.

Authors:  James J Pestka; Zahidul Islam; Chidozie J Amuzie
Journal:  Toxicol Lett       Date:  2008-02-23       Impact factor: 4.372

Review 4.  Biological detoxification of the mycotoxin deoxynivalenol and its use in genetically engineered crops and feed additives.

Authors:  Petr Karlovsky
Journal:  Appl Microbiol Biotechnol       Date:  2011-06-21       Impact factor: 4.813

5.  In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonist.

Authors:  Sumner H Burstein; Mark A Tepper
Journal:  Pharmacol Res Perspect       Date:  2013-12-15

6.  Cellular responses to T-2 toxin and/or deoxynivalenol that induce cartilage damage are not specific to chondrocytes.

Authors:  Yang Lei; Zhao Guanghui; Wang Xi; Wang Yingting; Lin Xialu; Yu Fangfang; Mary B Goldring; Guo Xiong; Mikko J Lammi
Journal:  Sci Rep       Date:  2017-05-22       Impact factor: 4.379

7.  Metabolism of the masked mycotoxin deoxynivalenol-3-glucoside in rats.

Authors:  Veronika Nagl; Heidi Schwartz; Rudolf Krska; Wulf-Dieter Moll; Siegfried Knasmüller; Mathias Ritzmann; Gerhard Adam; Franz Berthiller
Journal:  Toxicol Lett       Date:  2012-08-04       Impact factor: 4.372

8.  Risk Assessment of Deoxynivalenol by Revisiting Its Bioavailability in Pig and Rat Models to Establish Which Is More Suitable.

Authors:  Manuel Jimmy Saint-Cyr; Agnès Perrin-Guyomard; Jacqueline Manceau; Paméla Houée; Jean-Michel Delmas; Jean-Guy Rolland; Michel Laurentie
Journal:  Toxins (Basel)       Date:  2015-12-01       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.